DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
Monday, March 23, 2026 1 min read
Key Takeaway: DiaMedica Therapeutics Inc. will release its full-year 2025 financial results on March 30, 2026, after market close. The company will also host a conference call on March 31, 2026, at 7:00 AM CT to provide a business update. This event highlights DiaMedica's ongoing commitment to transparency and investor relations.
Market Sentiment Analysis
POSITIVE FACTORS
DiaMedica is focused on developing novel treatments for significant health issues.
The company is actively engaging with investors through a conference call.
The upcoming financial results could indicate positive growth.
Full Press Release Details
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke (AIS), today announced that its full-year 2025 financial results will be released after the markets close on Monday, March 30th. DiaMedica will host a live conference call on Tuesday, March 31st at 7:00 AM Central Time to provide a business update and discuss financial resu
Frequently Asked Questions
When will DiaMedica report its financial results?
DiaMedica will report its full-year 2025 financial results on March 30, 2026.
What time is the conference call for updates?
The conference call will take place on March 31, 2026, at 7:00 AM Central Time.
What conditions is DiaMedica focused on treating?
DiaMedica is developing treatments for preeclampsia, fetal growth restriction, and acute ischemic stroke.
Where will the financial results be released?
The financial results will be released after the markets close on March 30, 2026.